The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a <scp>48‐week</scp> randomized phase 4 study: <scp>STAR</scp> study-Reference-Cited by-同舟云学术

The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48‐week randomized phase 4 study: STAR study

Published:2022-10-18 Issue:3 Volume:101 Page:
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmologica

Author:

Li Xiaoxin¹²^ORCID,Qu Jinfeng²^ORCID,Su Guanfang³,Yu Suqin⁴,Zhang Yongjin⁵,Sadda Srini Vas⁶⁷,

Affiliation:

1. Xiamen Eye Center of Xiamen University Xiamen China

2. Department of Ophthalmology Peking University People's Hospital Beijing China

3. Department of Ophthalmology The Second Hospital of Jilin University Jilin China

4. Department of Ophthalmology Shanghai General Hospital of Shanghai Jiao Tong University Shanghai China

5. Department of Ophthalmology & Visual Science Eye and ENT Hospital of Fudan University Shanghai China

6. Doheny Image Reading Center, Doheny Eye Institute University of California Los Angeles (UCLA) Affiliated Los Angeles California USA

7. Department of Ophthalmology David Geffen School of Medicine at University of California Los Angeles California Los Angeles USA

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aos.15272

Reference34 articles.

1. Treat-and-Extend Regimens for the Management of Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: Consensus and Recommendations From the Asia-Pacific Vitreo-retina Society

2. Quantitative Changes in Pigment Epithelial Detachment Area and Volume Predict Retreatment in Polypoidal Choroidal Vasculopathy

3. Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

4. Polypoidal Choroidal Vasculopathy

5. Anti‐VEGF therapy for neovascular AMD and polypoidal choroidal vasculopathy;Cheung G.C.M.;Asia Pacific Journal of Ophthalmology (Phila),2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the First-Dose Anti-VEGF Anatomical Response in Polypoidal Choroidal Vasculopathy Patients: Correlation with the Third-Dose Response and Risk Factor Analysis;Ophthalmic Research;2023-12-18

2. Factors Influencing Visual Acuity in Patients with Active Subfoveal Circumscribed Polypoidal Choroidal Vasculopathy and Changes in Imaging Parameters;Diagnostics;2023-09-21

3. Anti-Vascular Endothelial Growth Factor Therapy Regimens for Polypoidal Choroidal Vasculopathy: A Systematic Review;Ophthalmologica;2023